Stroke diagnosis with lab-on-a-chip
A magnetic-based sensing platform with increased sensitivity has been developed for integration into lab-on-a-chip systems. The methodology consists of moving the magnetic particles to the most sensitive spot of the sensor. To demonstrate its effectiveness, the protein S100betabeta, a diagnostic marker for stroke, was used as target protein.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Medical device technology - 20(2009), 5 vom: 21. Sept., Seite 15-7 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parton, E [VerfasserIn] |
|---|
| Themen: |
Evaluation Study |
|---|
| Anmerkungen: |
Date Completed 01.12.2009 Date Revised 10.12.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM19225605X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM19225605X | ||
| 003 | DE-627 | ||
| 005 | 20231223192650.0 | ||
| 007 | tu | ||
| 008 | 231223s2009 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0641.xml |
| 035 | |a (DE-627)NLM19225605X | ||
| 035 | |a (NLM)19852176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parton, E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stroke diagnosis with lab-on-a-chip |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2009 | ||
| 500 | |a Date Revised 10.12.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a A magnetic-based sensing platform with increased sensitivity has been developed for integration into lab-on-a-chip systems. The methodology consists of moving the magnetic particles to the most sensitive spot of the sensor. To demonstrate its effectiveness, the protein S100betabeta, a diagnostic marker for stroke, was used as target protein | ||
| 650 | 4 | |a Evaluation Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Nerve Growth Factors |2 NLM | |
| 650 | 7 | |a S100 Calcium Binding Protein beta Subunit |2 NLM | |
| 650 | 7 | |a S100 Proteins |2 NLM | |
| 700 | 1 | |a Lagae, L |e verfasserin |4 aut | |
| 700 | 1 | |a Borghs, G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medical device technology |d 1990 |g 20(2009), 5 vom: 21. Sept., Seite 15-7 |w (DE-627)NLM091700507 |x 1048-6690 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2009 |g number:5 |g day:21 |g month:09 |g pages:15-7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2009 |e 5 |b 21 |c 09 |h 15-7 | ||